Press Coverage
What’s Next Post-COVID-19: The Next Normal
“When we move out of the pandemic, the world has to be prepared.” —Sagar Anisingaraju, Saama Saama’s Chief Strategy Officer and Others Opine on What
September 1, 2020
Read the latest news from Saama.
“When we move out of the pandemic, the world has to be prepared.” —Sagar Anisingaraju, Saama Saama’s Chief Strategy Officer and Others Opine on What
AI Gives Biotechs the Speed They Need to Compete with Big Pharma “The next generation of successful biotechs will be technology-enabled clinical companies that use
AI is poised to bring transformational change to drug development processes. Find out why BiopharmaTrend.com named Saama one of 2020’s top AI companies to watch
Saama’s Jonathan Burr Talks with DPharm about Accelerating Clinical Development Increased amounts of data and greater complexity have driven drug development costs and timelines way
Failure Is Not an Option The coronavirus pandemic forced the life sciences industry to ramp up drug research in unprecedented ways, but the rush has
To get a better idea of what the future of healthcare will look like and what technology we can expect, PM360 asked 10 experts about
The Remote Monitoring Revolution Is Here to Stay COVID-19 has focused worldwide attention on clinical trials and the urgent need for the rapid development of
CAMPBELL, CA – (May 5, 2020) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, and iNDX.Ai, a leading Multi-omics Data Analytics
